Progress Of Prevention On Orthopedic Deep Venous Thrombosis

Deep vein thrombosis as the most common complication of orthopedic surgery, more and more attention in the clinic, at present there are a lot of deep vein thrombosis prevention guide, but the various guidelines for thromboprophylaxis drug selection and use of time are the lack of a high level of evidence to support. The antithrombotic drugs is often accompanied by bleeding risk, need adequate attention. In this paper, the three elements of deep vein thrombosis:venous blood stagnation, vein wall damage and hypercoagulable state analysis, elaborated the incidence of venous thrombosis in orthopedic profound reasons. While risk factors for deep vein thrombosis orthopedic divided into strong, medium and weak three grades, and cited the incidence of common people. In this paper, the physical and the subsequent deep vein thrombosis prophylaxis drug measures were adopted to analyze, by comparing the new anticoagulant drugs and traditional anticoagulants, optional major orthopedic surgery sulfonamide up liver Kwai anticoagulant sodium, and knee arthroplasty More recommended rivaroxaban, is still recommended that aspirin and warfarin anticoagulation therapy as a regular. For because of lower extremity soft tissue trauma patients using plaster bandages brake usually ignore their higher risk of venous thrombosis, therefore, we recommend the use of anticoagulant drugs also need to if necessary. For the lower extremity long bone fractures in patients with early recovery of limb length and fixed through surgery can effectively reduce the incidence of venous thrombosis. For hip and knee replacement surgery limb, extending anticoagulant medications for better returns when necessary.